Literature DB >> 30376200

Type I interferons differentially modulate maternal host immunity to infection by Listeria monocytogenes and Salmonella enterica serovar Typhimurium during pregnancy.

Gerard Agbayani1,2, Kristina Wachholz2, Shawn P Murphy3,4, Subash Sad1, Lakshmi Krishnan1,2.   

Abstract

PROBLEM: IFN-alpha receptor deficiency (IFNAR-/- ) enhances immunity to Listeria monocytogenes (LM) and Salmonella enterica serovar Typhimurium (ST) in the non-pregnant state by inhibiting pathogen-induced immune cell death. However, the roles of IFNAR signaling in modulating immunity to infection during pregnancy are not well understood. METHOD OF STUDY: C57BL/6J wild-type (WT) and IFNAR-/- mice were infected systemically with LM or ST. Bacterial burden in spleen and individual placentas was enumerated at day 3 post-infection. Immune cell numbers and percentages were quantified in spleen and individual placentas, respectively, through flow cytometry. Cytokine expression in serum, spleen, and individual placentas was measured through cytometric bead array.
RESULTS: IFNAR-/- mice exhibited decreased splenic monocyte numbers in non-pregnant and pregnant state, and an altered distribution of placental immune cell types in the non-infected state. IFNAR-/- mice controlled LM infection more effectively than WT mice even during pregnancy. This correlated with enhanced serum IL-12 expression, despite reduced splenic monocyte numbers relative to WT controls. In contrast, pregnant IFNAR-/- mice unlike their non-pregnant counterparts exhibited increased susceptibility to ST infection, which was associated with decreased serum IL-12 expression.
CONCLUSION: Type I IFN responses differentially impact host resistance to LM and ST infection during pregnancy through modulation of immune cell distribution and cytokine responses.
© 2018 Her Majesty the Queen in Right of Canada American Journal of Reproductive Immunology © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Listeriazzm321990; zzm321990Salmonellazzm321990; Type I Interferon; cytokines; pregnancy

Year:  2018        PMID: 30376200      PMCID: PMC6344237          DOI: 10.1111/aji.13068

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  43 in total

Review 1.  Role of cytokines in the innate immune response to intracellular pathogens.

Authors:  S Stenger; M Röllinghoff
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

2.  Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection.

Authors:  L P Cousens; J S Orange; H C Su; C A Biron
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

3.  Persistent LCMV infection is controlled by blockade of type I interferon signaling.

Authors:  John R Teijaro; Cherie Ng; Andrew M Lee; Brian M Sullivan; Kathleen C F Sheehan; Megan Welch; Robert D Schreiber; Juan Carlos de la Torre; Michael B A Oldstone
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

4.  Lack of functional selectin-ligand interactions enhances innate immune resistance to systemic Listeria monocytogenes infection.

Authors:  Gerard Agbayani; Komal Gurnani; Ahmed Zafer; Subash Sad; Lakshmi Krishnan
Journal:  J Leukoc Biol       Date:  2017-12-27       Impact factor: 4.962

5.  Type I interferon promotes alveolar epithelial type II cell survival during pulmonary Streptococcus pneumoniae infection and sterile lung injury in mice.

Authors:  Barbara B Maier; Anastasiya Hladik; Karin Lakovits; Ana Korosec; Rui Martins; Julia B Kral; Ildiko Mesteri; Birgit Strobl; Mathias Müller; Ulrich Kalinke; Miriam Merad; Sylvia Knapp
Journal:  Eur J Immunol       Date:  2016-07-12       Impact factor: 5.532

Review 6.  Interferon-stimulated genes and their antiviral effector functions.

Authors:  John W Schoggins; Charles M Rice
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

7.  Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.

Authors:  Victoria Auerbuch; Dirk G Brockstedt; Nicole Meyer-Morse; Mary O'Riordan; Daniel A Portnoy
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

8.  Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection.

Authors:  Javier A Carrero; Boris Calderon; Emil R Unanue
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

9.  Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung.

Authors:  Kim S LeMessurier; Hans Häcker; Liying Chi; Elaine Tuomanen; Vanessa Redecke
Journal:  PLoS Pathog       Date:  2013-11-07       Impact factor: 6.823

Review 10.  Monocytes and macrophages in pregnancy and pre-eclampsia.

Authors:  Marijke M Faas; Floor Spaans; Paul De Vos
Journal:  Front Immunol       Date:  2014-06-30       Impact factor: 7.561

View more
  4 in total

Review 1.  Protective and Pathogenic Effects of Interferon Signaling During Pregnancy.

Authors:  Rebecca L Casazza; Helen M Lazear; Jonathan J Miner
Journal:  Viral Immunol       Date:  2019-09-23       Impact factor: 2.257

Review 2.  Impact of Type I Interferons on Susceptibility to Bacterial Pathogens.

Authors:  Adeline Peignier; Dane Parker
Journal:  Trends Microbiol       Date:  2021-02-02       Impact factor: 18.230

Review 3.  Emerging Roles of Autophagy and Inflammasome in Ehrlichiosis.

Authors:  Tyler R Tominello; Edson R A Oliveira; Shah S Hussain; Amr Elfert; Jakob Wells; Brandon Golden; Nahed Ismail
Journal:  Front Immunol       Date:  2019-05-08       Impact factor: 7.561

Review 4.  Nod-like Receptors: Critical Intracellular Sensors for Host Protection and Cell Death in Microbial and Parasitic Infections.

Authors:  Abdulkareem Olarewaju Babamale; Szu-Ting Chen
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.